Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Zometa Acquisition Cost Of $713 Per Dose Is 2% Higher Than Aredia

Executive Summary

Novartis' hypercalcemia therapy Zometa will be available at the wholesale acquisition cost of $713.65 per 4 mg dose. Shipments to wholesalers are expected to begin during the week of Aug. 27.
Advertisement

Related Content

Novartis Zometa Picks Up 17% Of Company’s Bisphosphonate Business
Novartis Zometa Picks Up 17% Of Company’s Bisphosphonate Business
Novartis Zomaril NDA Filing Awaits More Data On QTc Prolongation
Novartis Zomaril NDA Filing Awaits More Data On QTc Prolongation
Novartis Zometa
Novartis Zometa
Novartis Alters Zometa Study Design Due To Renal Function Concerns
Advertisement
UsernamePublicRestriction

Register

PS038410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel